Nephrectomy: Clinical Trials

4 trials of Nephrectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Active not recruiting 1, Completed 1

Follow Nephrectomy: new trials by email Literature Review of Nephrectomy trials Research Report on Nephrectomy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Bone Scan, Carboplatin, Computed Tomography - Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3RecruitingChildren's Oncology Group16562025-04-152026-08-25
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Axitinib plus Toripalimab, nephrectomy - Renal Cell Carcinoma, Neoadjuvant
Phase 3RecruitingZHOU FANGJIAN2982023-04-192026-03-17
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Nephrectomy, Nivolumab, Patient Observation - Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma
Phase 3Active not recruitingNational Cancer Institute (NCI)8192017-04-282026-11-13
Clinical Trial to Assess the Importance of Nephrectomy
Nephrectomy, Sunitinib alone - Metastatic Renal Cell Carcinoma
Phase 3CompletedAssistance Publique - Hôpitaux de Paris4522009-09-092025-09-05

Conditions studied

Carcinoma, Renal Cell (3)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)  ·  ZHOU FANGJIAN (1)

Countries

Canada (2)  ·  United States (2)  ·  Australia (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  New Zealand (1)

Top investigators

Arnaud Mejean, MD PhD (1)  ·  Elizabeth A Mullen (1)  ·  Fangjian Zhou, Professor (1)  ·  Lauren Harshman (1)

Results publications

PMID 24338498, PMID 29860937, PMID 33526329, PMID 34187771, PMID 38942046, PMID 41693026

NIH funding

U10CA180820 (1), U10CA180886 (1)